Private Advisor Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,982
Closed -$247K 2029
2023
Q1
$247K Buy
+1,982
New +$272K ﹤0.01% 1680
2022
Q4
Sell
-6,802
Closed -$917K 1698
2022
Q3
$917K Sell
6,802
-315
-4% -$48.2K 0.01% 956
2022
Q2
$1.06M Sell
7,117
-2,285
-24% -$349K 0.01% 1033
2022
Q1
$1.6M Sell
9,402
-2,526
-21% -$424K 0.01% 887
2021
Q4
$3.08M Sell
11,928
-2,303
-16% -$631K 0.02% 641
2021
Q3
$3.88M Buy
14,231
+1,263
+10% +$401K 0.02% 613
2021
Q2
$2.9M Buy
12,968
+2
+0% +$377 0.03% 613
2021
Q1
$1.42M Sell
12,966
-4,775
-27% -$507K 0.01% 849
2020
Q4
$1.45M Buy
17,741
+9,621
+118% +$944K 0.02% 769
2020
Q3
$562K Buy
8,120
+5,620
+225% +$403K 0.01% 1012
2020
Q2
$167K Buy
+2,500
New +$125K ﹤0.01% 1440

Other funds holding BNTX

Private Advisor Group's BNTX Position: Q2 2023 in Review

Private Advisor Group sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 1,982 shares — an estimated $247K sold.

Private Advisor Group first reported a position in BNTX in Q2 2020 and held it in 11 quarters. The position peaked at $3.88M in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • Private Advisor Group reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • Private Advisor Group sold 1,982 BioNTech shares in Q2 2023, an estimated $247K.
  • Private Advisor Group first reported a position in BioNTech in Q2 2020 and held it in 11 quarters.
  • Private Advisor Group's BioNTech position peaked at $3.88M in Q3 2021.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.